Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Chugai Pharmaceutical Number of Employees 2020-2024 | CHGCY

Chugai Pharmaceutical number of employees from 2020 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
  
Chugai Pharmaceutical Annual Employee Count
2023
2022 7,771
2021 7,664
2020 7,555
2019 7,394
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $7.926B
CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.787B 30.32
Takeda Pharmaceutical (TAK) Japan $43.178B 8.99
Merck (MKKGY) Germany $19.884B 17.81
Astellas Pharma (ALPMY) Japan $19.363B 17.83
Sandoz Group AG (SDZNY) Switzerland $19.197B 0.00
United Therapeutics (UTHR) United States $17.245B 16.96
Summit Therapeutics (SMMT) United States $14.343B 0.00
Neurocrine Biosciences (NBIX) United States $12.441B 32.94
Shionogi (SGIOY) Japan $12.135B 11.62
Catalent (CTLT) United States $10.693B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.513B 7.35
Orion OYJ (ORINY) Finland $6.653B 18.71
Madrigal Pharmaceuticals (MDGL) United States $6.601B 0.00
Ionis Pharmaceuticals (IONS) United States $5.879B 0.00
Corcept Therapeutics (CORT) United States $5.741B 43.48
Crinetics Pharmaceuticals (CRNX) United States $5.533B 0.00
PTC Therapeutics (PTCT) United States $3.269B 0.00
Dyne Therapeutics (DYN) United States $3.085B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.786B 16.67
Arrowhead Pharmaceuticals (ARWR) United States $2.662B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.587B 11.72
Soleno Therapeutics (SLNO) United States $2.332B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.248B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.983B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.942B 0.00
Evotec AG (EVO) Germany $1.807B 0.00
Xencor (XNCR) United States $1.645B 0.00
Ocular Therapeutix (OCUL) United States $1.547B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.543B 0.00
Harrow (HROW) United States $1.521B 0.00
Indivior (INDV) United States $1.399B 5.70
ARS Pharmaceuticals (SPRY) United States $1.371B 0.00
Guardian Pharmacy Services (GRDN) United States $1.304B 0.00
Cassava Sciences (SAVA) United States $1.258B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.193B 0.00
Enliven Therapeutics (ELVN) United States $1.177B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.116B 0.00
Ardelyx (ARDX) United States $1.116B 0.00
Collegium Pharmaceutical (COLL) United States $0.976B 5.33
Relay Therapeutics (RLAY) United States $0.937B 0.00
Bioventus (BVS) United States $0.903B 28.54
Cronos Group (CRON) Canada $0.791B 0.00
USANA Health Sciences (USNA) United States $0.752B 13.94
Tourmaline Bio (TRML) United States $0.689B 0.00
Exscientia (EXAI) United Kingdom $0.674B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.657B 0.00
ProKidney (PROK) United States $0.623B 0.00
Altimmune (ALT) United States $0.601B 0.00
Elite Pharmaceuticals (ELTP) United States $0.553B 0.00
Savara (SVRA) United States $0.547B 0.00
Organogenesis (ORGO) United States $0.531B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.484B 196.14
Larimar Therapeutics (LRMR) United States $0.483B 0.00
OmniAb (OABI) United States $0.481B 0.00
Zevra Therapeutics (ZVRA) United States $0.475B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Korro Bio (KRRO) United States $0.466B 0.00
Verve Therapeutics (VERV) United States $0.455B 0.00
Xeris Biopharma Holdings (XERS) United States $0.455B 0.00
Siga Technologies (SIGA) United States $0.450B 5.25
KalVista Pharmaceuticals (KALV) United States $0.424B 0.00
Silence Therapeutics (SLN) United Kingdom $0.418B 0.00
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Esperion Therapeutics (ESPR) United States $0.414B 0.00
Akebia Therapeutics (AKBA) United States $0.406B 0.00
4D Molecular Therapeutics (FDMT) United States $0.371B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.344B 0.00
Avita Medical (RCEL) United States $0.330B 0.00
Sage Therapeutics (SAGE) United States $0.329B 0.00
Lyell Immunopharma (LYEL) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Lexeo Therapeutics (LXEO) United States $0.257B 0.00
Pyxis Oncology (PYXS) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.254B 0.00
Acrivon Therapeutics (ACRV) United States $0.247B 0.00
Nektar Therapeutics (NKTR) United States $0.216B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.215B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.198B 0.00
Nanobiotix S.A (NBTX) France $0.191B 0.00
Heron Therapeutics (HRTX) United States $0.189B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Galectin Therapeutics (GALT) United States $0.171B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Cardiol Therapeutics (CRDL) Canada $0.152B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.149B 0.00
Context Therapeutics (CNTX) United States $0.143B 0.00
Avalo Therapeutics (AVTX) United States $0.140B 0.00
Telomir Pharmaceuticals (TELO) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.112B 0.00
Century Therapeutics (IPSC) United States $0.107B 0.00
Journey Medical (DERM) United States $0.105B 0.00
Karyopharm Therapeutics (KPTI) United States $0.105B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Fractyl Health (GUTS) United States $0.101B 0.00
Regulus Therapeutics (RGLS) United States $0.098B 0.00
Relmada Therapeutics (RLMD) United States $0.095B 0.00
CASI Pharmaceuticals (CASI) China $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Vivani Medical (VANI) United States $0.085B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.080B 21.05
ESSA Pharma (EPIX) Canada $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
Inotiv (NOTV) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
OptiNose (OPTN) United States $0.069B 0.00
Scienture Holdings (SCNX) United States $0.068B 0.00
AlloVir (ALVR) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Citius Pharmaceuticals (CTXR) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.057B 0.00
Nutriband (NTRB) United States $0.054B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Unicycive Therapeutics (UNCY) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.039B 0.00
Carisma Therapeutics (CARM) United States $0.039B 0.00
FibroGen (FGEN) United States $0.037B 0.00
BioLineRx (BLRX) Israel $0.037B 0.00
DURECT (DRRX) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Surrozen (SRZN) United States $0.030B 0.00
BioVie (BIVI) United States $0.030B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
CERo Therapeutics Holdings (CERO) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
GlycoMimetics (GLYC) United States $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
MEI Pharma (MEIP) United States $0.020B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Inhibikase Therapeutics (IKT) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.013B 0.00
NRx Pharmaceuticals (NRXP) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.009B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Molecular Templates (MTEM) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.10
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.53
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 40.20